GoAI
Get started
Miahelsa Holdings Corporation logo

Miahelsa Holdings Corporation

7129.T

JPXHealthcareMedical - Pharmaceuticals

Open in GoAI

Latest quote

¥1,162

+¥3.00 · +0.26%

Aug 24, 3:30 PM JST

7129.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Miahelsa Holdings Corporation, based in Tokyo, Japan, operates a diverse portfolio of services primarily encompassing the pharmaceutical, childcare, and elder care sectors. In its pharmaceutical segment, the company manages dispensing pharmacies and provides specialized home infusion therapy. Its extensive range of elder care provisions includes in-home assistance, visiting care, outpatient services, and various residential solutions such as cohabitation care for individuals with dementia, welfare centers, assisted living facilities, and private nursing homes. Furthermore, Miahelsa operates health promotion centers, welfare schools, nurseries, and after-school programs. The corporation also engages in the wholesale distribution of food ingredients for school lunches and offers convenient meal delivery services. Established in 1966, the company has a significant history in these critical industries.

Industry
Medical - Pharmaceuticals
Sector
Healthcare
Headquarters
JP
CEO
Fumie Aoki
Listed since
Oct 1, 2021
Employees
1,838

Market position

Day range

Current ¥1,162

52-week range

Current ¥1,162

Open
¥1,156
Previous close
¥1,159
Volume
2K
1.55× average
Average volume
1.29K
Average daily volume
Market cap
3.26B JPY
Beta
0.32
Market reference 1
50-day average
¥1,144.74
+1.51% above average
200-day average
¥1,146
+1.40% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
4.52B JPY
P/E (TTM)
18.29×
P/B (TTM)
0.84×
P/S (TTM)
0.13×
EV / EBITDA
4.22×
Earnings yield
6.31%
Free cash flow yield
16.13%
Dividend yield
2.58%

Profitability & efficiency

Gross margin
10.71%
Operating margin
3.14%
Net margin
0.71%
Return on equity
5.13%
Return on assets
1.29%
Return on invested capital
3.35%

Financial health

Debt / equity
0.76×
Current ratio
0.99×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends12%8%3%-1%Gross margin, FY2021: 9.73%Gross margin, FY2022: 9.04%Gross margin, FY2023: 9.53%Gross margin, FY2024: 10.04%Gross margin, FY2025: 10.74%Operating margin, FY2021: 0.96%Operating margin, FY2022: 0.86%Operating margin, FY2023: 1.74%Operating margin, FY2024: 2.69%Operating margin, FY2025: 3.32%Net margin, FY2021: 1.49%Net margin, FY2022: 0.94%Net margin, FY2023: 0.02%Net margin, FY2024: 1.26%Net margin, FY2025: 0.81%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 9.73%. Gross margin FY2022 9.04%. Gross margin FY2023 9.53%. Gross margin FY2024 10.04%. Gross margin FY2025 10.74%. Operating margin FY2021 0.96%. Operating margin FY2022 0.86%. Operating margin FY2023 1.74%. Operating margin FY2024 2.69%. Operating margin FY2025 3.32%. Net margin FY2021 1.49%. Net margin FY2022 0.94%. Net margin FY2023 0.02%. Net margin FY2024 1.26%. Net margin FY2025 0.81%.

Income trends

Revenue

24.85B JPY+4.30%

Operating income

824.3M JPY+28.56%

Net income

200.85M JPY-33.02%
Income trends across reported periods27.34B JPY17.4B JPY7.46B JPY−2.48B JPYRevenue, FY2021: 19.51B JPYRevenue, FY2022: 22.25B JPYRevenue, FY2023: 22.72B JPYRevenue, FY2024: 23.83B JPYRevenue, FY2025: 24.85B JPYOperating income, FY2021: 186.37M JPYOperating income, FY2022: 191.11M JPYOperating income, FY2023: 395.23M JPYOperating income, FY2024: 641.18M JPYOperating income, FY2025: 824.3M JPYNet income, FY2021: 291.57M JPYNet income, FY2022: 209.58M JPYNet income, FY2023: 5.53M JPYNet income, FY2024: 299.87M JPYNet income, FY2025: 200.85M JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 19.51B JPY. Revenue FY2022 22.25B JPY. Revenue FY2023 22.72B JPY. Revenue FY2024 23.83B JPY. Revenue FY2025 24.85B JPY. Operating income FY2021 186.37M JPY. Operating income FY2022 191.11M JPY. Operating income FY2023 395.23M JPY. Operating income FY2024 641.18M JPY. Operating income FY2025 824.3M JPY. Net income FY2021 291.57M JPY. Net income FY2022 209.58M JPY. Net income FY2023 5.53M JPY. Net income FY2024 299.87M JPY. Net income FY2025 200.85M JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue24.85B JPY23.83B JPY22.72B JPY22.25B JPY19.51B JPY
Cost of goods sold22.18B JPY21.43B JPY20.56B JPY20.24B JPY17.61B JPY
Gross profit2.67B JPY2.39B JPY2.16B JPY2.01B JPY1.9B JPY
Selling, general, and administrative1.85B JPY1.75B JPY1.77B JPY1.82B JPY1.71B JPY
Operating expenses1.85B JPY1.75B JPY1.77B JPY1.82B JPY1.71B JPY
Interest income3.87M JPY1.04M JPY68K JPY75K JPY90K JPY
Interest expense44.76M JPY37.45M JPY30.84M JPY35.24M JPY27.63M JPY
Depreciation and amortization588.08M JPY627.83M JPY654.28M JPY643.75M JPY524.38M JPY
Operating income824.3M JPY641.18M JPY395.23M JPY191.11M JPY186.37M JPY
Net income200.85M JPY299.87M JPY5.53M JPY209.58M JPY291.57M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
32.34

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates68.1727.82-12.53-52.88Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25
Q3 2023, reported Aug 9, 2023: actual -15.87, estimate —, surprise —, Comparison unavailable. Q4 2023, reported Nov 9, 2023: actual 2.8, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Feb 8, 2024: actual 59.82, estimate —, surprise —, Comparison unavailable. Q2 2024, reported May 14, 2024: actual -44.53, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 8, 2024: actual 26.19, estimate —, surprise —, Comparison unavailable. Q4 2024, reported Nov 11, 2024: actual 17.53, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 12, 2025: actual 37.05, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 14, 2025: actual 32.34, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates6.45B6.04B5.64B5.23BQ3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25
Q3 2023, reported Aug 9, 2023: actual 5.48B JPY, estimate —, surprise —, Comparison unavailable. Q4 2023, reported Nov 9, 2023: actual 5.52B JPY, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Feb 8, 2024: actual 5.89B JPY, estimate —, surprise —, Comparison unavailable. Q2 2024, reported May 14, 2024: actual 5.84B JPY, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 8, 2024: actual 5.74B JPY, estimate —, surprise —, Comparison unavailable. Q4 2024, reported Nov 11, 2024: actual 5.76B JPY, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 12, 2025: actual 6.2B JPY, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 14, 2025: actual 6.13B JPY, estimate —, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥30.00

2025 complete year0.0% since 2022

2026 partial: ¥17.00

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Sep 29, 2026

¥13.00

Semi-Annual

Record Sep 30, 2026 · Payment Sep 29, 2026

DividendUpcoming

Ex-dividend Mar 30, 2027

¥17.00

Semi-Annual

Record Mar 31, 2027 · Payment Mar 30, 2027

Dividend

Ex-dividend Mar 30, 2026

¥17.00

Semi-Annual

Record Mar 31, 2026 · Payment Jun 29, 2026

Dividend

Ex-dividend Sep 29, 2025

¥13.00

Semi-Annual

Record Sep 30, 2025 · Payment Dec 4, 2025

Dividend

Ex-dividend Mar 28, 2025

¥17.00

Semi-Annual

Record Mar 31, 2025 · Payment Jun 27, 2025

Dividend

Ex-dividend Sep 27, 2024

¥13.00

Semi-Annual

Record Sep 30, 2024 · Payment Dec 3, 2024

7129.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,987

-0.34%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,797

+0.57%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,895

0.00%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,210

+0.12%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,858

+0.86%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,406.5

+0.82%

Continue in GoAI

Research 7129.T

research.disclaimer